Kailera Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
January 08, 2025 08:05 ET
|
Kailera Therapeutics, Inc.
Kailera Therapeutics today announced the appointment of Laurie Stelzer as Chief Financial Officer.
Kailera Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 08:15 ET
|
Kailera Therapeutics, Inc.
Ron Renaud, Kailera's President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025.
Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer
November 12, 2024 08:00 ET
|
Kailera Therapeutics, Inc.
Today, Kailera Therapeutics announced the appointment of Scott Akamine as Chief Legal Officer.
Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions
October 01, 2024 07:00 ET
|
Kailera Therapeutics, Inc.
Kailera today announced its launch as a clinical-stage biopharmaceutical company advancing next-generation therapies for obesity and related conditions.